Linda Laux

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Orrin Devinsky, J. Helen Cross, Linda Laux et al. · New England Journal of Medicine · 2017 · 1.6K citations · Full text

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Orrin Devinsky, Eric D. Marsh, Daniel J. Friedman et al. · The Lancet Neurology · 2015 · 890 citations

Cannabis Use, Psychotropic Medication, Neuropharmacology +5

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 868 citations

Placebo-controlled Phase 3, Neuropharmacology, Pharmacotherapy +4

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

Lieven Lagae, Joseph Sullivan, Kelly G. Knupp et al. · The Lancet · 2019 · 348 citations

Dravet Syndrome, Fenfluramine Hydrochloride, Medicine +5

Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel

Elaine Wirrell, Linda Laux, Elizabeth Donner et al. · Pediatric Neurology · 2017 · 274 citations

Medicine, Inherited Metabolic Disease, Pediatrics +1